Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

284.10
+3.611.29%
Pre-market: 283.48-0.6200-0.22%08:28 EDT
Volume:203.70K
Turnover:57.39M
Market Cap:5.66B
PE:29.26
High:285.90
Open:276.77
Low:275.60
Close:280.49
52wk High:326.63
52wk Low:160.80
Shares:19.94M
Float Shares:19.35M
Volume Ratio:1.22
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.85
PE(LYR):46.35

Loading ...

Ligand Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $289 From $243

THOMSON REUTERS
·
Apr 30

Ligand Pharmaceuticals Is Maintained at Outperform by RBC Capital

Dow Jones
·
Apr 28

RBC Raises Price Target on Ligand Pharmaceuticals to $252 From $235, Keeps Outperform Rating

MT Newswires Live
·
Apr 28

Deals of the day-Mergers and acquisitions

Reuters
·
Apr 28

Ligand price target raised to $260 from $250 at BofA

TIPRANKS
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Eton Pharmaceuticals (ETON) and Ligand Pharma (LGND)

TIPRANKS
·
Apr 27

XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday

Benzinga_recent_news
·
Apr 27

Ligand Pharma to acquire fellow biotech royalty rights buyer XOMA for $739 million

Reuters
·
Apr 27

Ligand to buy XOMA Royalty for $39 per share in cash, CVR included

Reuters
·
Apr 27

XOMA Royalty Corp - Stockholders to Receive One CVR per Share for 75% of Net Litigation Proceeds

THOMSON REUTERS
·
Apr 27

XOMA Royalty Corp - Ligand Increases 2026 Revenue Guidance to $270 Mln-$310 Mln; Royalties $225 Mln-$250 Mln

THOMSON REUTERS
·
Apr 27

XOMA Royalty Corp - Ligand Raises 2026 Adj EPS Guidance to $8.50-$9.50; Expects $1.50 Accretion to Adj EPS in 2027

THOMSON REUTERS
·
Apr 27

XOMA Royalty Corp - Ligand to Buy XOMA Royalty for $39.00 per Share in Cash, Equity Value $739 Mln

THOMSON REUTERS
·
Apr 27

XOMA Shares Gain 5.4% Premarket After Report Ligand Pharmaceuticals Buying Co for Nearly $740 Mln

THOMSON REUTERS
·
Apr 27

BRIEF-Ligand Pharmaceuticals Is Buying Xoma For Nearly $740 Million - WSJ

Reuters
·
Apr 27

Xoma Royalty Shares Edge Up Premarket on Report of Takeover by Ligand

Dow Jones
·
Apr 27

Ligand Pharmaceuticals Is Buying XOMA for Nearly $740 Million - WSJ

THOMSON REUTERS
·
Apr 27

Ligand Pharmaceuticals' Deal for XOMA Would Value XOMA at $39 a Share - WSJ

THOMSON REUTERS
·
Apr 27

Ligand Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 22

Ligand Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
Apr 16